• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重要的金属蛋白酶酶组在选定的骨骼系统疾病。

Importance of Metalloproteinase Enzyme Group in Selected Skeletal System Diseases.

机构信息

Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15269 Bialystok, Poland.

Department of Aesthetic Medicine, Medical University of Bialystok, 15267 Bialystok, Poland.

出版信息

Int J Mol Sci. 2023 Dec 5;24(24):17139. doi: 10.3390/ijms242417139.

DOI:10.3390/ijms242417139
PMID:38138968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10743273/
Abstract

Bone tissue is a dynamic structure that is involved in maintaining the homeostasis of the body due to its multidirectional functions, such as its protective, endocrine, or immunological role. Specialized cells and the extracellular matrix (ECM) are responsible for the remodeling of specific bone structures, which alters the biomechanical properties of the tissue. Imbalances in bone-forming elements lead to the formation and progression of bone diseases. The most important family of enzymes responsible for bone ECM remodeling are matrix metalloproteinases (MMPs)-enzymes physiologically present in the body's tissues and cells. The activity of MMPs is maintained in a state of balance; disruption of their activity is associated with the progression of many groups of diseases, including those of the skeletal system. This review summarizes the current understanding of the role of MMPs in bone physiology and the pathophysiology of bone tissue and describes their role in specific skeletal disorders. Additionally, this work collects data on the potential of MMPs as bio-markers for specific skeletal diseases.

摘要

骨骼组织是一种具有多向功能的动态结构,它在维持机体的内环境稳定方面发挥着重要作用,例如保护、内分泌或免疫作用。特定的细胞和细胞外基质(ECM)负责重塑特定的骨骼结构,从而改变组织的生物力学特性。成骨元素的失衡会导致骨骼疾病的发生和发展。负责骨骼 ECM 重塑的最重要的酶家族是基质金属蛋白酶(MMPs)-这些酶在体内组织和细胞中生理性存在。MMPs 的活性处于平衡状态;其活性的破坏与许多疾病群体的进展有关,包括骨骼系统的疾病。本综述总结了 MMPs 在骨骼生理学和骨骼组织病理生理学中的作用,并描述了它们在特定骨骼疾病中的作用。此外,这项工作还收集了 MMPs 作为特定骨骼疾病生物标志物的潜力的数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ba/10743273/500726c9cabb/ijms-24-17139-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ba/10743273/500726c9cabb/ijms-24-17139-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ba/10743273/500726c9cabb/ijms-24-17139-g001.jpg

相似文献

1
Importance of Metalloproteinase Enzyme Group in Selected Skeletal System Diseases.重要的金属蛋白酶酶组在选定的骨骼系统疾病。
Int J Mol Sci. 2023 Dec 5;24(24):17139. doi: 10.3390/ijms242417139.
2
Bone tissue remodeling and development: focus on matrix metalloproteinase functions.骨组织重塑与发育:聚焦基质金属蛋白酶的功能。
Arch Biochem Biophys. 2014 Nov 1;561:74-87. doi: 10.1016/j.abb.2014.07.034. Epub 2014 Aug 23.
3
Matrix Metalloproteinases in Bone Resorption, Remodeling, and Repair.骨吸收、重塑和修复中的基质金属蛋白酶
Prog Mol Biol Transl Sci. 2017;148:203-303. doi: 10.1016/bs.pmbts.2017.05.001. Epub 2017 Jun 20.
4
Pathogenesis and therapeutic implications of matrix metalloproteinases in intervertebral disc degeneration: A comprehensive review.基质金属蛋白酶在椎间盘退变中的发病机制及治疗意义:全面综述。
Biochimie. 2023 Nov;214(Pt B):27-48. doi: 10.1016/j.biochi.2023.05.015. Epub 2023 May 31.
5
Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions.骨中的基质金属蛋白酶及其抑制剂:调控与功能概述
Front Biosci. 2006 Sep 1;11:2949-66. doi: 10.2741/2024.
6
Matrix metalloproteinases (MMPs) in health and disease: an overview.健康与疾病中的基质金属蛋白酶(MMPs):综述
Front Biosci. 2006 May 1;11:1696-701. doi: 10.2741/1915.
7
Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.炎症介导的人类疾病中基质金属蛋白酶抑制剂的生理特性、功能及研究趋势
Curr Med Chem. 2023;30(18):2075-2112. doi: 10.2174/0929867329666220823112731.
8
Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.下一代基质金属蛋白酶抑制剂——新策略带来新前景。
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):1927-1939. doi: 10.1016/j.bbamcr.2017.06.009. Epub 2017 Jun 19.
9
Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration.在椎间盘老化和退变过程中金属蛋白酶及其抑制剂的表达和调控。
Spine J. 2013 Mar;13(3):331-41. doi: 10.1016/j.spinee.2012.02.027. Epub 2013 Jan 29.
10
Expression of extracellular matrix molecules, MMPs and TIMPs in alveolar bone, cementum and periodontal ligaments during rat tooth eruption.大鼠牙齿萌出过程中牙槽骨、牙骨质和牙周韧带细胞外基质分子、基质金属蛋白酶和组织金属蛋白酶抑制剂的表达
J Electron Microsc (Tokyo). 2003;52(6):593-604. doi: 10.1093/jmicro/52.6.593.

引用本文的文献

1
Plasma Concentrations of Matrilysins (MMP-7, MMP-26) and Stromelysins (MMP-3, MMP-10) as Diagnostic Biomarkers in High-Grade Serous Ovarian Cancer Patients.基质溶素(MMP - 7、MMP - 26)和基质溶解素(MMP - 3、MMP - 10)的血浆浓度作为高级别浆液性卵巢癌患者的诊断生物标志物
Int J Mol Sci. 2025 Jun 13;26(12):5661. doi: 10.3390/ijms26125661.
2
Application of responsive nano-drug carriers in bone tumor chemotherapy.响应性纳米药物载体在骨肿瘤化疗中的应用。
J Bone Oncol. 2025 May 16;52:100689. doi: 10.1016/j.jbo.2025.100689. eCollection 2025 Jun.
3
Title Changes in Plasma Levels of Selected Matrix Metalloproteinases (MMPs) Enzymes in Patients with Osgood-Schlatter Disease (OSD).

本文引用的文献

1
Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases Ratio: A Biomarker of Bone Resorption in Geriatric Osteoporosis?基质金属蛋白酶/金属蛋白酶组织抑制剂比值:老年骨质疏松症骨吸收的生物标志物?
Ann Geriatr Med Res. 2023 Jun;27(2):151-157. doi: 10.4235/agmr.23.0024. Epub 2023 May 19.
2
Osteometabolism: Metabolic Alterations in Bone Pathologies.骨代谢:骨骼病理学中的代谢改变。
Cells. 2022 Dec 6;11(23):3943. doi: 10.3390/cells11233943.
3
Utility of Matrix Metalloproteinases in the Diagnosis, Monitoring and Prognosis of Ovarian Cancer Patients.
奥施拉德病(OSD)患者血浆中所选基质金属蛋白酶(MMPs)酶水平的变化
J Clin Med. 2024 Sep 24;13(19):5655. doi: 10.3390/jcm13195655.
基质金属蛋白酶在卵巢癌患者诊断、监测及预后中的应用价值
Cancer Manag Res. 2022 Nov 30;14:3359-3382. doi: 10.2147/CMAR.S385658. eCollection 2022.
4
The expression of metalloproteinases in the lumbar disc correlates strongly with Pfirrmann MRI grades in lumbar spinal fusion patients.腰椎间盘金属蛋白酶的表达与腰椎融合患者的Pfirrmann MRI分级密切相关。
Brain Spine. 2022 Feb 5;2:100872. doi: 10.1016/j.bas.2022.100872. eCollection 2022.
5
Membrane-type 1 matrix metalloproteinase as predictor of survival and candidate therapeutic target in Ewing sarcoma.膜型 1 基质金属蛋白酶作为尤文肉瘤生存预测因子和候选治疗靶点。
Pediatr Blood Cancer. 2022 Dec;69(12):e29959. doi: 10.1002/pbc.29959. Epub 2022 Sep 15.
6
Matrix Metalloproteinases in Dental and Periodontal Tissues and Their Current Inhibitors: Developmental, Degradational and Pathological Aspects.基质金属蛋白酶在牙齿和牙周组织中的作用及其当前抑制剂:发育、降解和病理方面。
Int J Mol Sci. 2022 Aug 11;23(16):8929. doi: 10.3390/ijms23168929.
7
Up-regulation of matrix metalloproteinase-9 in primary bone tumors and its association with tumor aggressiveness.原发性骨肿瘤中基质金属蛋白酶-9的上调及其与肿瘤侵袭性的关联。
Mol Biol Rep. 2022 Oct;49(10):9409-9427. doi: 10.1007/s11033-022-07798-z. Epub 2022 Aug 24.
8
Endoglin and MMP14 Contribute to Ewing Sarcoma Spreading by Modulation of Cell-Matrix Interactions.内皮糖蛋白和 MMP14 通过调节细胞-基质相互作用促进尤文肉瘤的扩散。
Int J Mol Sci. 2022 Aug 4;23(15):8657. doi: 10.3390/ijms23158657.
9
The Predictive Role of MMP-2, MMP-9, TIMP-1 and TIMP-2 Serum Levels in the Complete Response of the Tumor to Chemotherapy in Breast Cancer Patients.血清基质金属蛋白酶-2、-9、-1 及 -2 水平对乳腺癌患者肿瘤化疗完全缓解的预测作用。
J Invest Surg. 2022 Jul;35(7):1544-1550. doi: 10.1080/08941939.2022.2080308. Epub 2022 May 30.
10
Translational Strategies to Target Metastatic Bone Disease.靶向转移性骨病的转化策略。
Cells. 2022 Apr 12;11(8):1309. doi: 10.3390/cells11081309.